Allspring Global Investments
CRL icon

Allspring Global Investments’s Charles River Laboratories CRL Stock Holding History

Allspring Global Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436M Sell
1,905,247
-88,069
-4% -$15.7M 0.67% 26
2026
Q1 		$349M Sell
1,993,316
-2,280
-0.1% -$423K 0.58% 25
2025
Q4 		$404M Sell
1,995,596
-182,345
-8% -$33.1M 0.65% 19
2025
Q3 		$371M Sell
2,177,941
-113,185
-5% -$18M 0.6% 21
2025
Q2 		$354M Buy
2,291,126
+516,521
+29% +$68.9M 0.59% 27
2025
Q1 		$259M Sell
1,774,605
-33,397
-2% -$5.6M 0.45% 46
2024
Q4 		$330M Buy
1,808,002
+47,221
+3% +$9.1M 0.53% 32
2024
Q3 		$347M Buy
1,760,781
+509,163
+41% +$106M 0.54% 31
2024
Q2 		$259M Buy
1,251,618
+132,802
+12% +$30.1M 0.42% 44
2024
Q1 		$303M Sell
1,118,816
-46,490
-4% -$11.1M 0.47% 35
2023
Q4 		$275M Sell
1,165,306
-29,920
-3% -$5.88M 0.46% 40
2023
Q3 		$234M Buy
1,195,226
+6,398
+0.5% +$1.31M 0.42% 42
2023
Q2 		$250M Buy
1,188,828
+31,963
+3% +$6.36M 0.4% 41
2023
Q1 		$233M Buy
1,156,865
+9,039
+0.8% +$2.05M 0.39% 47
2022
Q4 		$250M Buy
1,147,826
+171,479
+18% +$37.4M 0.43% 40
2022
Q3 		$192M Buy
976,347
+331,084
+51% +$71.5M 0.34% 49
2022
Q2 		$138M Buy
645,263
+610,182
+1,739% +$149M 0.23% 103
2022
Q1 		$9.96M Buy
35,081
+17,734
+102% +$5.47M 0.01% 882
2021
Q4 		$6.54M Buy
+17,347
New +$6.74M 0.01% 1084

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments's CRL Position: Q2 2026 in Review

Allspring Global Investments reduced its Charles River Laboratories (CRL) stake by 4.4% in Q2 2026, selling an estimated $15.7M and leaving 1,905,247 shares worth $436M. The position accounts for 0.67% of the portfolio, ranked #26.

Allspring Global Investments first reported a position in CRL in Q4 2021 and has held it in 19 quarters since. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Allspring Global Investments held 1,905,247 shares of Charles River Laboratories worth $436M as of Q2 2026.
  • Allspring Global Investments sold 88,069 Charles River Laboratories shares in Q2 2026, an estimated $15.7M.
  • Charles River Laboratories made up 0.67% of Allspring Global Investments's portfolio in Q2 2026, its #26 holding.
  • Allspring Global Investments first reported a position in Charles River Laboratories in Q4 2021 and has held it in 19 quarters since.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.